Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00949130 · ClinicalTrials.gov registry record · Phase 2
Comparative Study of NXL103 Versus Linezolid in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
A Phase 2 study of Acute Bacterial Skin and Skin Structure Infections, sponsored by Novexel.
- Completed
- Registry status
- Phase 2
- Development phase
- 180
- Enrollment target
- 15
- Study locations
NCT00949130: Completed Phase 2 study of Acute Bacterial Skin and Skin Structure Infections, sponsored by Novexel.
NCT00949130 is a Phase 2 study of Acute Bacterial Skin and Skin Structure Infections that has completed, run by Novexel. The registered enrollment target is 180 participants. The trial reports 15 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00949130, a Phase 2 study of Acute Bacterial Skin and Skin Structure Infections, has completed, sponsored by Novexel.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 180 participants
- Enrollment target
- 15
- Study locations
Study Summary
The objective of this study is to evaluate the efficacy and safety of oral NXL103 vs. established treatment of acute bacterial infection in adults.
Conditions Studied
Interventions
- DRUG NXL103
- DRUG Linezolid
Study Locations (15)
California
- Sharp Chula Vista Research Office - Chula Vista
- Fountain Valley Regional Hospital and Medical Center - Fountain Valley
- Sharp Grossmont Research Office - La Mesa
- Tri-City Oceanside Office - Oceanside
Other
- Roosevelt Hospital - Guatemala City
- UNICAR - Guatemala City
- Military Health Center - Guatemala City
- Private Hospital - Quetzaltenango
Georgia
- Southeast Regional Research Group - Columbus
- Southeast Regional Research Group - Savannah
Minnesota
- Hennepin County Medical Center - Minneapolis
- Infectious Diseaes MPLS-LTD - Minneapolis
Idaho
- Idaho Falls Infectious Diseases - Idaho Falls
Montana
- Mercury Street Medical Group - Butte
Pennsylvania
- RPS Infectious Diseases - West Reading
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2009-11 |
| Est. Completion | 2010-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00949130
The ClinicalTrials.gov registry entry for NCT00949130 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novexel, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Bacterial Skin and Skin Structure Infections appearing as the primary indexed condition, and to 2 interventions - of which NXL103 is the first listed.
NCT00949130 reports 15 study locations spanning 7 distinct geographic areas - top geographies include California, Other, Georgia.
Frequently Asked Questions
What is clinical trial NCT00949130 about?
NCT00949130 is a clinical study titled "Comparative Study of NXL103 Versus Linezolid in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)". The objective of this study is to evaluate the efficacy and safety of oral NXL103 vs. established treatment of acute bacterial infection in adults.
What is the current status of trial NCT00949130?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 180 participants. The study started on 2009-11. Estimated completion is 2010-03.
What conditions does trial NCT00949130 study?
This clinical trial studies the following conditions: Acute Bacterial Skin and Skin Structure Infections.
What interventions are being tested in trial NCT00949130?
The interventions under investigation include: NXL103 (DRUG), Linezolid (DRUG).
Who is sponsoring clinical trial NCT00949130?
This trial is sponsored by Novexel, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00949130 being conducted?
This trial has 15 study locations across California, Georgia, Idaho, Minnesota, Montana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Bacterial Skin and Skin Structure Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.